Prevalence, Risk Factors, and Treatment Outcomes of Isoniazid- and Rifampicin- Mono-Resistant Pulmonary Tuberculosis in Lima, Peru

BACKGROUND: Isoniazid and rifampicin are the two most efficacious first-line agents for tuberculosis (TB) treatment. We assessed the prevalence of isoniazid and rifampicin mono-resistance, associated risk factors, and the association of mono-resistance on treatment outcomes. METHODS: A prospective,...

Descripción completa

Detalles Bibliográficos
Autores principales: Villegas, Leonela, Otero, Larissa, Sterling, Timothy R., Huaman, Moises A., Van der Stuyft, Patrick, Gotuzzo, Eduardo, Seas, Carlos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4821555/
https://www.ncbi.nlm.nih.gov/pubmed/27045684
http://dx.doi.org/10.1371/journal.pone.0152933

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4821555/
https://www.ncbi.nlm.nih.gov/pubmed/27045684
http://dx.doi.org/10.1371/journal.pone.0152933

Ejemplares similares